0001127602-17-015594.txt : 20170426
0001127602-17-015594.hdr.sgml : 20170426
20170426201215
ACCESSION NUMBER: 0001127602-17-015594
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170425
FILED AS OF DATE: 20170426
DATE AS OF CHANGE: 20170426
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMGEN INC
CENTRAL INDEX KEY: 0000318154
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 953540776
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320
BUSINESS PHONE: (805)447-1000
MAIL ADDRESS:
STREET 1: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320
FORMER COMPANY:
FORMER CONFORMED NAME: AMGEN
DATE OF NAME CHANGE: 19870305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Such Annette Louise
CENTRAL INDEX KEY: 0001635760
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37702
FILM NUMBER: 17785889
MAIL ADDRESS:
STREET 1: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320-1799
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2017-04-25
0000318154
AMGEN INC
AMGN
0001635760
Such Annette Louise
ONE AMGEN CENTER DRIVE
THOUSAND OAKS
CA
91320-1799
1
VP, Finance and CAO
Common Stock
2017-04-25
4
F
0
40
163.14
D
7907
D
Common Stock
2017-04-26
4
F
0
44
164.70
D
7863
D
These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 99 RSUs which vest on 4/25/2018; 1,334 RSUs which vest in one installment of 657 on 8/1/2017 and one installment of 677 on 8/1/2018; 191 RSUs which vest in one installment of 94 on 4/24/2018 and one installment of 97 on 4/24/2019; 798 RSUs which vest in one installment of 393 on 4/24/2018 and one installment of 405 on 4/24/2019; and 575 RSUs which vest in installments of 189 on 5/3/2018, 190 on 5/3/2019 and 196 on 5/3/2020. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
These shares include 156 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount.
/s/ Annette L. Such
2017-04-26